Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 40, No. 3-4, 2008   

Free Abstract     Article (References)     Article (PDF 129 KB)     

Paper

Uveitis Secondary to Bacterial Products
James T. Rosenbaum, Holly L. Rosenzweig, Justine R. Smith, Tammy M. Martin, Stephen R. Planck

Oregon Health and Science University, Portland, Oreg., USA

Address of Corresponding Author

Ophthalmic Res 2008;40:165-168 (DOI: 10.1159/000119870)


 goto top of page Key Words

  • Endotoxin
  • Muramyl dipeptide
  • NOD2
  • Uveitis

 goto top of page Abstract

Bacteria are suspected contributors to several forms of immune-mediated, noninfectious forms of uveitis including that associated with ankylosing spondylitis, sarcoidosis, Behçet's disease and inflammatory bowel disease. Endotoxin (lipopolysaccharide)-induced uveitis has been a widely used model for more than 2 decades. Both rats and mice develop a transient, bilateral anterior uveitis after a systemic injection of endotoxin. Inflammation posterior to the lens is generally milder than anterior segment inflammation. The uveitis is severer if the lipopolysaccharides are injected intraocularly. The model has been invaluable in helping to identify mediators induced in the inflamed eye and in testing pharmacologic approaches to reduce eye inflammation. Muramyl dipeptide is another bacterial cell component that can induce uveitis in laboratory animals. Muramyl dipeptide is especially intriguing as a cause of uveitis because it activates the intracellular protein, Nod2, and mutations in the NOD2 gene are the cause of the autosomal dominant form of uveitis that is characteristic of Blau syndrome. Since a mutation in a gene that codes for a protein which senses a bacterial product consistently results in uveitis, it is critical to understand more fully the mechanisms by which bacterial products cause uveitis in laboratory animals.

Copyright © 2008 S. Karger AG, Basel


 goto top of page Author Contacts

James T. Rosenbaum
Oregon Health and Science University
3181 S.W. Sam Jackson Park Rd., L467AD
Portland, OR 97239 (USA)
Tel. +1 503 494 5023, Fax +1 503 494 6875, E-Mail rosenbaj@ohsu.edu


 goto top of page Article Information

Published online: April 18, 2008
Number of Print Pages : 4
Number of Figures : 0, Number of Tables : 0, Number of References : 26

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 18421233)
Download Citation




For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2010 S. Karger AG, Basel